SEC 13F Intelligence

Roman Butler Fullerton & Co / LLY

Roman Butler Fullerton & Co’s Eli Lilly & Co Position

Does Roman Butler Fullerton & Co own Eli Lilly & Co (LLY)? Yes — 7.3K shares worth $7M (+1.92% of its 13F portfolio) as of Q1 2026, up from 7.3K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
7.3K
% of Portfolio
+1.92%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $227,000Q4 ’18Q1 ’19: $388,000Q2 ’19: $332,000Q3 ’19: $298,000Q4 ’19: $351,000Q4 ’19Q1 ’20: $370,000Q2 ’20: $438,000Q3 ’20: $395,000Q4 ’20: $489,000Q4 ’20Q1 ’21: $621,000Q2 ’21: $767,000Q3 ’21: $793,000Q4 ’21: $917,000Q4 ’21Q1 ’22: $2MQ2 ’22: $4MQ3 ’22: $4MQ4 ’22: $4MQ4 ’22Q1 ’23: $4MQ2 ’23: $4MQ3 ’23: $6MQ4 ’23: $6MQ4 ’23Q1 ’24: $7MQ2 ’24: $9MQ3 ’24: $9MQ4 ’24: $8MQ4 ’24Q1 ’25: $7MQ2 ’25: $7MQ3 ’25: $6MQ4 ’25: $8MQ4 ’25Q1 ’26: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20267.3K$7M+1.92%
Q4 20257.3K$8M+2.08%
Q3 20257.2K$6M+1.57%
Q2 20259.0K$7M+2.15%
Q1 20258.7K$7M+2.56%
Q4 20249.7K$8M+2.49%
Q3 202410.0K$9M+2.76%
Q2 20249.9K$9M+3.01%
Q1 20249.8K$7M+2.70%
Q4 20239.8K$6M+2.44%
Q3 202310.0K$6M+2.87%
Q2 20239.9K$4M+2.06%
Q1 20239.3K$4M+1.79%
Q4 202210.8K$4M+2.00%
Q3 202210.8K$4M+2.25%
Q2 202212.7K$4M+2.33%
Q1 20227.8K$2M+1.04%
Q4 20213.3K$917,000+0.41%
Q3 20213.3K$793,000+0.37%
Q2 20213.3K$767,000+0.37%
Q1 20213.3K$621,000+0.31%
Q4 20202.9K$489,000+0.29%
Q3 20202.7K$395,000+0.26%
Q2 20202.7K$438,000+0.31%
Q1 20202.7K$370,000+0.33%
Q4 20192.7K$351,000+0.23%
Q3 20192.7K$298,000+0.21%
Q2 20193.0K$332,000+0.22%
Q1 20193.0K$388,000+0.27%
Q4 20182.0K$227,000+0.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Roman Butler Fullerton & Co’s full portfolio or all institutional holders of LLY.